ibrutinib,rituximab
abbvie,janssen
['mantle,(-dismantle)', 'lymphoma']
#ash22 | martin dreyling: efficacy and safety of #ibrutinib combined with standard first-line treatment or as substitute for #autosct in younger patients with mantle cell lymphoma. results from the #triangletrial #mcl 
Latest research in hematology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published @ilpensiero | @think2it